The US Centers for Medicare and Medicaid Services made some important decisions about flexibility for state Medicaid agencies trying to manage drug costs in the last week of June.
First, it told Massachusetts it can’t run a closed formulary while still taking mandatory rebates – but made clear it...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?